AlphaFold predicted structure
PAICS · P22234

Mean pLDDT
95.8/ 100
Very high
425 residues
Confidence breakdown
- Very high(≥ 90)94%
- Confident(70–90)5%
- Low(50–70)1%
- Very low(< 50)1%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
Fetal anomalies
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalphosphoribosylaminoimidazole carboxylase deficiency
Polyhydramnios
acute myeloid leukemia
neoplasm
non-small cell lung carcinoma
breast carcinoma
breast cancer
colorectal carcinoma
central nervous system cancer
glioma
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Bifunctional phosphoribosylaminoimidazole carboxylase/phosphoribosylaminoimidazole succinocarboxamide synthetase
Bifunctional phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazole succinocarboxamide synthetase catalyzing two reactions of the de novo purine biosynthetic pathway
PAICS · P22234

Mean pLDDT
95.8/ 100
Very high
425 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0